Cargando…
β-sitosterol inhibits trimethylamine production by regulating the gut microbiota and attenuates atherosclerosis in ApoE(–/–) mice
The intestinal microbial metabolite trimethylamine (TMA), which is activated by flavin monooxygenase (FMO) to produce trimethylamine-N-oxide (TMAO), has been implicated in the pathogenesis of atherosclerosis (AS), leading to the development of therapeutic strategies for AS. This study aimed to inves...
Autores principales: | Wu, Weiping, Liu, Wugao, Wang, Huafu, Wang, Wei, Chu, Weihua, Jin, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663806/ https://www.ncbi.nlm.nih.gov/pubmed/36386330 http://dx.doi.org/10.3389/fcvm.2022.986905 |
Ejemplares similares
-
Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
por: Wang, BingYu, et al.
Publicado: (2021) -
Gut Microbiota and Atherosclerosis—Focusing on the Plaque Stability
por: Shen, Xinyi, et al.
Publicado: (2021) -
Targeting Trimethylamine N-Oxide: A New Therapeutic Strategy for Alleviating Atherosclerosis
por: Jing, Lele, et al.
Publicado: (2022) -
Dietary α-Linolenic Acid-Rich Flaxseed Oil Ameliorates High-Fat Diet-Induced Atherosclerosis via Gut Microbiota-Inflammation-Artery Axis in ApoE(−/−) Mice
por: Li, Yiwei, et al.
Publicado: (2022) -
Ginger essential oil and citral ameliorates atherosclerosis in ApoE(−/−) mice by modulating trimethylamine-N-oxide and gut microbiota
por: Panyod, Suraphan, et al.
Publicado: (2023)